Skip to content

Outcome Evaluation of Minority AIDS Initiative Programs in the New York EMA

Outcome Evaluation of Minority AIDS Initiative Programs in the New York EMA

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00273403
Enrollment
5100
Registered
2006-01-09
Start date
1999-11-30
Completion date
2006-11-30
Last updated
2006-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections

Keywords

HIV, Minority Groups, Health Services Accessibility, Quality of Life

Brief summary

This outcome evaluation effort provides the opportunity to learn what programmatic approaches effectively address two of the most difficult hurdles in HIV health services delivery: (1) getting people who would benefit from health care to use it and (2) getting people who do use health care to do so more consistently and effectively. The New York HIV Planning Council (through MHRA) has funded 23 agencies to achieve these objectives for people of color with HIV disease.

Detailed description

All clients are assessed upon entry into the program, have their service utilization tracked, and then are reassessed at three, six, and twelve months following program entry. The main client-level data elements collected during baseline and follow-up interviews are the following: * Biological markers (including HIV status, viral load, t-cell count) * Demographic characteristics * Adherence to treatment * Barriers to care * Social support * Substance use and treatment * Functional health status Functional Health Status is used in this evaluation as the primary measure of final client outcomes. The Functional Health Status items we use are from the ACTG SF-21 (a modified version of the Medical Outcomes Study instrument). The overall evaluation objectives are to: * Describe the change in functional health status for different populations and groups of clients. * Identify services or constellations of services and intensity of services associated with change in functional health status. * Assess whether programs meet intermediate objectives (decreased drug use, increased service use, improved housing stability). * Identify barriers to access to and maintenance in care.

Interventions

BEHAVIORALMaintenance in Care Services
BEHAVIORALAccess to Care Services

Sponsors

Public Health Solutions
CollaboratorOTHER
The New York Academy of Medicine
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
0 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* HIV-positive * Not in HIV care, or difficulty being maintained in HIV care * HIV-negative but at high risk of HIV infection

Exclusion criteria

* HIV-negative and not at high risk of HIV infection

Design outcomes

Primary

MeasureTime frame
Functional Health Status (ACTG SF-21): at 3, 6, and 12 mos.

Secondary

MeasureTime frame
Housing stability: at 3, 6, and 12 months
Substance use: at 3, 6, and 12 months
Whether receiving HIV primary care: at 3, 6, and 12 months
Whether on HIV meds: at 3, 6, and 12 months

Countries

United States

Contacts

Primary ContactElana Behar, MA
ebehar@nyam.org212-822-7374
Backup ContactJohn Chin, PhD
jchin@nyam.org212-419-3537

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026